the technology

First, the performance of the best companies: Shares in animal husbandry (600 195): mid-year report 2009 income per share of 0.38 yuan.
The company in 2008 operating highlights: First, the affair proceeded to grow animal vaccines, beast vaccines, sales revenues reached 981 million yuan (foot and jaws disease vaccine about 4 billion yuan (1.05 billion ml), blue ear pig disease vaccine about 1.7 billion yuan (36 of 32 provinces triumphing the tender rate of 78%)), an addition of 19%;
second fared business a actual increase in profitability.
09 year results growth drivers: the Ministry of Agriculture of new vaccines to safe the approval and put into production. in 2009 the company has three new species may start
vaccine production: First, type A foot and mouth disease vaccine. because 09 A foot and mouth disease happened in China in early-type pestilence, the Ministry of Agriculture intends to start the A-type foot and mouth disease vaccine production. which, in animal husbandry, stock, Lanzhou Veterinary Research Institute, the maximum likely to win a pre-production; Second, live attenuated PRRS vaccine. Ministry of Agriculture intends to present has 19 fabrication undertakings in the elected four starts live attenuated PRRS vaccine production; third caress vaccines (rabies vaccine), bio-pharmaceutical company under the Jiangxi fondle vaccine production may be completed the first half of testing, and may 09 production acceptance of the Ministry of Agriculture. These fashionable products such as access to production, the company ambition have Company: Jinyu Group (600 201), mid-year report earnings per share of 0.11 yuan.
Company completed the merger of the original morale of Kim Paul biopharmaceuticals factory in Inner Mongolia and the acquisition of bio-pharmaceutical Co., Ltd. Yangzhou Yobo narrated work, bio-pharmaceutical industry the fast growth of assets, formed a production and sales of state compulsory vaccination of cattle and sheep ploughs as the core productions of special pattern of the vaccine, a total of 4 GMP criterion workshop, the fast development of the biopharmaceutical industry works continuously to reserve the industry ranked second in six annuals .
industry leader, Paul
completion of the acquisition is a set of spiritual development, production and sales of high-tech enterprise, is designated by the Ministry of Agriculture foot and mouth disease vaccine production is an of five appointed manufacturer. Paul Ling company situated in the foot and mouth disease cattle, sheep and swine fever vaccine production leaching spleen, now has 3 have been certified by the Ministry of Agriculture GMP production workshops, and supporting laboratories and closed-all overspection of pigs, cattle, small animal feeding shelter, power and stamina supply system FMD yearly production capacity of up to 2.4 billion ml. Company and the Tropical and Subtropical Agriculture Ministry Key Laboratory of Animal Virology, Fudan University, Veterinary Institute of Military Medical Sciences, Chinese veterinary supervision, the National Animal Disease Control Center and many additional research units in the genetic engineering vaccine, heat-protective agency, the districts of new product development in close cooperation with guiding technology avails. After years of rapid development, product sales network has covered thirty-one provinces, the market share each year. < br> Biological Pharmaceutical Co., Ltd. Yangzhou Yobo is the accretion of the Group 07, a bio-pharmaceutical enterprise, namely the team apt effect optimization of the industrial layout, an essential step in the inflating development. The company is effectively engaged in the blue ear pig vaccine creation and sales , have a GMP certified at the Ministry of Agriculture, the production workshop. As of immediately, blue ear piglet vaccine production capability of 300 million ml, the mall share of over 30%, ranked premier in the nation.
the first discovery in technology
Biological technology breakthrough is the development of the largest source of technology companies, constantly means an explosive growth in capacity, which method publishing money as profit. is the merely citizen lab of veterinary vaccines, Kim Paul Ling suspended in the foot and mouth disease civilization and antigen concentration and purification technology has been successfully reached the international level, the production effectiveness and quality of products additional by 20 times than the original, the technology, will entirely solve the existence of major animal catching foot and mouth disease vaccine immunity time is short, side effects big problem, antigen concentration and purification techniques tin be purified foot and mouth disease antigen 100 concentration. when also completed China's first genetically engineered vaccine pilot line installation. Meanwhile, the company developed in cooperation with Fudan University to engineered vaccines,